NBYNovaBay Pharmaceuticals, Inc.

NYSE novabay.com


$ 0.49 $ 0.00 (-0.43 %)    

Friday, 30-Aug-2024 15:58:31 EDT
QQQ $ 461.29 $ -14.46 (-3.04 %)
DIA $ 410.26 $ -5.96 (-1.43 %)
SPY $ 551.70 $ -11.60 (-2.06 %)
TLT $ 97.57 $ 1.26 (1.31 %)
GLD $ 230.29 $ -1.00 (-0.43 %)
$ 0.4846
$ 0.48 x 200
-- x --
-- - --
$ 0.36 - $ 44.80
70,927
na
2.37M
$ -0.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-26-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-29-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 03-25-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 03-26-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-07-2019 06-30-2019 10-Q
22 05-15-2019 03-31-2019 10-Q
23 03-29-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-07-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-21-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-10-2017 06-30-2017 10-Q
30 05-11-2017 03-31-2017 10-Q
31 03-23-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-11-2016 06-30-2016 10-Q
34 05-12-2016 03-31-2016 10-Q
35 03-04-2016 12-31-2015 10-K
36 11-16-2015 09-30-2015 10-Q
37 08-13-2015 06-30-2015 10-Q
38 05-14-2015 03-31-2015 10-Q
39 03-26-2015 12-31-2014 10-K
40 11-12-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 novabay-pharmaceuticals-q2-eps-137-misses-123-estimate-sales-240m-miss-315m-estimate

NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(1.37) per share which missed the analyst consensus estimate o...

 whats-going-on-with-novabay-pharmaceuticals-nby-stock

NovaBay Pharmaceuticals shares are lower by 66% over the trailing five sessions. The company last week announced the pricing of...

 why-novabay-pharmaceuticals-nby-stock-is-down-60

NovaBay Pharmaceuticals shares are trading lower by 61% during Friday's session. The company announced the pricing of its p...

 novabay-pharmaceuticals-announces-preliminary-net-revenue-for-the-second-quarter-of-2024-of-24m-versus-consensus-of-315m-and-for-the-first-half-of-2024-of-5m-primarily-derived-from-the-companys-eyecare-products

Net revenue from the Company's eyecare products increased by 9% for both the second quarter and the first half of 2024 over...

Core News & Articles

NovaBay® Pharmaceuticals, Inc. (NYSE:NBY), a company developing and commercializing high-quality eyecare products, and Eyenovia...

 novabay-pharmaceuticals-plans-1-for-35-reverse-stock-split-and-reveals-receipt-of-nyse-american-notice-regarding-stockholders-equity

The Company anticipates that the 1-for-35 reverse stock split will be effective as of 4:15 p.m. New York City time on Thursday,...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION